Cited by 112Cardiomyopathy and Myosin StudiesCardiovascular Function and Risk FactorsCardiac electrophysiology and arrhythmias

Phosphorylation of cardiac Myosin-binding protein-C is a critical mediator of diastolic function

Open access
Rosas, Paola C., Liu, Yang, Abdalla, Mohamed I., Thomas, Candice M., Kidwell, David T., Dusio, Giuseppina F., Mukhopadhyay, Dhriti, Kumar, Rajesh +9 more·2015·Circulation: Heart Failure

Abstract

Background—: Heart failure (HF) with preserved ejection fraction (HFpEF) accounts for ≈50% of all cases of HF and currently has no effective treatment. Diastolic dysfunction underlies HFpEF; therefore, elucidation of the mechanisms that mediate relaxation can provide new potential targets for treatment. Cardiac myosin-binding protein-C (cMyBP-C) is a thick filament protein that modulates cross-bridge cycling rates via alterations in its phosphorylation status. Thus, we hypothesize that phosphorylated cMyBP-C accelerates the rate of cross-bridge detachment, thereby enhancing relaxation to mediate diastolic function. Methods and Results—: We compared mouse models expressing phosphorylation-deficient cMyBP-C(S273A/S282A/S302A)–cMyBP-C(t3SA), phosphomimetic cMyBP-C(S273D/S282D/S302D)–cMyBP-C(t3SD), and wild-type-control cMyBP-C(tWT) to elucidate the functional effects of cMyBP-C phosphorylation. Decreased voluntary running distances, increased lung/body weight ratios, and increased brain natriuretic peptide levels in cMyBP-C(t3SA) mice demonstrate that phosphorylation deficiency is associated with signs of HF. Echocardiography (ejection fraction and myocardial relaxation velocity) and pressure/volume measurements (−d P /d t min , pressure decay time constant τ -Glantz, and passive filling stiffness) show that cMyBP-C phosphorylation enhances myocardial relaxation in cMyBP-C(t3SD) mice, whereas deficient cMyBP-C phosphorylation causes diastolic dysfunction with HFpEF in cMyBP-C(t3SA) mice. Simultaneous force and [Ca 2+ ] i measurements on intact papillary muscles show that enhancement of relaxation in cMyBP-C(t3SD) mice and impairment of relaxation in cMyBP-C(t3SA) mice are not because of altered [Ca 2+ ] i handling, implicating that altered cross-bridge detachment rates mediate these changes in relaxation rates. Conclusions—: cMyBP-C phosphorylation enhances relaxation, whereas deficient phosphorylation causes diastolic dysfunction and phenotypes resembling HFpEF. Thus, cMyBP-C is a potential target for treatment of HFpEF.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circheartfailure.114.001550

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The excised MYBPC3 region spans 2 of 3 clustered phosphorylatable serines (S275, S284, and S304) that are key regulatory sites in MYBPC3 targeted by protein kinase A (PKA).

    “Moreover, the region spans 2 of 3 clustered phosphorylatable serines (S275, S284, and S304) that are key regulatory sites in MYBPC3 targeted by protein kinase A (PKA) (Figure 5A).”

    From Splice-Junction-Based Mapping of Alternative Isoforms in the Human Proteome (2019) · cites this paper as Rosas et al., 2015

  • Phosphorylation of S275, S284, and S304 in MYBPC3 by PKA and other kinases causes the MYBPC3 N-terminal domain to dissociate from myosin heavy chain and increase cardiac crossbridge formation.

    “The phosphorylation of S275, S284, and S304 in MYBPC3 by PKA and other kinases causes the MYBPC3 N-terminal domain to dissociate from myosin heavy chain and, hence, increase cardiac crossbridge formation (Rosas et al., 2015).”

    From Splice-Junction-Based Mapping of Alternative Isoforms in the Human Proteome (2019) · cites this paper as Rosas et al., 2015

  • Mutagenesis replacement of these serines with phosphonegative mimetic alanines in animal models led to hearts with abnormal relaxation velocity but not ejection fraction, suggesting the sites may function in diastolic regulation.

    “Mutagenesis replacement of these serines with phosphonegative mimetic alanines in animal models led to hearts with abnormal relaxation velocity but not ejection fraction (Rosas et al., 2015), suggesting the sites may function in diastolic regulation.”

    From Splice-Junction-Based Mapping of Alternative Isoforms in the Human Proteome (2019) · cites this paper as Rosas et al., 2015

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rosas, P. C., Liu, Y., Abdalla, M. I., Thomas, C. M., Kidwell, D. T., Dusio, G. F., Mukhopadhyay, D., Kumar, R., Baker, K. M., Mitchell, B. M., Powers, P. A., Fitzsimons, D. P., Patel, B. G., Warren, C. M., Solaro, R. J., Moss, R. L., & Tong, C. W.
Affiliations
Texas A&M Health Science Center (US)
Venue
Circulation: Heart Failure
Published
2015-05
Volume
8
Issue
3
Pages
582-594
ISSN
  • 1941-3289 (ISSN-L)
  • 1941-3297
OpenAlex
W2121747051
Cited by
112
References
52
Citations by year
2026: 6 · 2025: 4 · 2024: 12 · 2023: 8 · 2022: 6 · 2021: 15 · 2020: 13 · 2019: 12 · 2018: 11 · 2017: 6 · 2016: 9 · 2015: 10
FWCI
8.73
Type
journal article
Language
en
Open access
Locations
  • Circulation Heart Failure (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Texas A and M University
  • National Institutes of Health (5p01hl094291-05)
  • National Heart, Lung, and Blood Institute (R37HL082900, K08HL114877, R37 HL82900, P01‑HL094291, P01HL062426)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
myosin binding protein C, phosphorylation, diastolic dysfunction, heart failure with preserved ejection fraction, myocardial relaxation, cross-bridge detachment, thick filaments, phosphomimetic mutant, calcium handling, papillary muscle, brain natriuretic peptide
MeSH terms
Myosin Binding Protein C, Animals, Blood Pressure, Carrier Proteins, Diastole, Genotype, Heart Failure, Kinetics, Mice, Transgenic, Mutation, Phenotype, Phosphorylation, Protein Processing, Post-Translational, Ventricular Function, Left, Cyclic AMP-Dependent Protein Kinases, Ventricular Dysfunction, Left

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review